图书馆订阅: Guest
医药载体系统评论综述

每年出版 6 

ISSN 打印: 0743-4863

ISSN 在线: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Endothelial Cells as Therapeutic Targets in Cancer: New Biology and Novel Delivery Systems

卷 20, 册 2&3, 2003, 14 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v20.i23.20
Get accessGet access

摘要

The significance of the endothelial cell as a target for antitumor therapy has been recognized for some time, but so far the results of clinical trials exploiting this approach have not been encouraging. The subject is likely to gain new momentum, however, following a number of important recent findings that shed new light on the origins and nature of tumor vasculature. Coupled with rapid developments in the use of phage-displayed peptide libraries to characterize the human vascular map, as well as highly selective delivery systems, this new understanding of tumor vascular biology should provide many fresh and exciting avenues to explore.

对本文的引用
  1. Hamad Islam, Moghimi S Moein, Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug, Expert Opinion on Drug Delivery, 5, 2, 2008. Crossref

  2. Orive G., Ali O.A., Anitua E., Pedraz J.L., Emerich D.F., Biomaterial-based technologies for brain anti-cancer therapeutics and imaging, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1806, 1, 2010. Crossref

  3. Patra Hirak Kumar, Dasgupta Anjan Kr, Cancer cell response to nanoparticles: criticality and optimality, Nanomedicine: Nanotechnology, Biology and Medicine, 8, 6, 2012. Crossref

  4. Emerich Dwaine F., Thanos Christopher G., The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis, Biomolecular Engineering, 23, 4, 2006. Crossref

  5. Aguilar Zoraida P., Targeted Drug Delivery, in Nanomaterials for Medical Applications, 2013. Crossref

  6. Brewer Erik, Lowman Anthony M., Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayers, Journal of Biomaterials Science, Polymer Edition, 25, 5, 2014. Crossref

  7. Dutta Majumder Dwijesh, Banerjee Rajat, Mukhopadhayay Sunit K, Ulrichs Christian, Mewis Inga, Samanta Arunava, Das Asit, Adhikary Sujit, Goswami Arunava, Nano-fabricated Materials in Cancer Treatment and Agri-biotech Applications: Buckyballs in Quantum Holy Grails, IETE Journal of Research, 52, 5, 2006. Crossref

  8. Zhang Yongming, Li Aidong, Wang Zheng, Han Zhikai, He Jie, Ma Jie, Antimetastatic activities of pegylated liposomal doxorubicin in a murine metastatic lung cancer model, Journal of Drug Targeting, 16, 9, 2008. Crossref

  9. Emerich Dwaine F., Thanos Christopher G., Targeted nanoparticle-based drug delivery and diagnosis, Journal of Drug Targeting, 15, 3, 2007. Crossref

  10. Moghimi S, Passive Targeting of Solid Tumors, in Nanotechnology for Cancer Therapy, 2006. Crossref

  11. Moghimi S. Moein, Hunter A. Christy, Murray J. Clifford, Nanomedicine: current status and future prospects, The FASEB Journal, 19, 3, 2005. Crossref

  12. Gelperina Svetlana, Nanocarriers and Drug Delivery, in Regional Cancer Therapy, 2007. Crossref

  13. Moghimi S. Moein, Hamad Islam, Factors Controlling Pharmacokinetics of Intravenously Injected Nanoparticulate Systems, in Nanotechnology in Drug Delivery, 2009. Crossref

  14. Moghimi S.M., Hunter A.C., Andresen T.L., Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective, Annual Review of Pharmacology and Toxicology, 52, 1, 2012. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain